6-K
BetterLife Pharma Inc. (BETRF)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 OF THE
SECURITIES EXCHANGE ACT OF 1934
For the month of June, 2020.
Commission File Number 333-161157
| BETTERLIFE PHARMA INC. |
|---|
| (Translation of registrant’s name into English) |
1275 WEST 6^TH^ AVENUE, #300
VANCOUVER, BC V6H 1A6
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)( 1): ____
Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6‑K if submitted solely to provide an attached annual report to security holders.
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____
Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6‑K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on which the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been the subject of a Form 6‑K submission or other Commission filing on EDGAR.
Exhibits:
| 99.1 | Material Change Report dated June 9, 2020 |
|---|
| 2 |
|---|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| BETTERLIFE PHARMA INC. | ||
|---|---|---|
| Date: June 9, 2020 | By: | /s/ Moira Ong |
| | Name: | Moira Ong |
| | Title: | Chief Financial Officer |
| 3 |
|---|
betrf_ex991.htm EXHIBIT 99.1
FORM 51-102F3
MATERIAL CHANGE REPORT
| Item 1 | Name and Address of Company |
|---|---|
| BetterLife Pharma Inc. (the “Company”)<br><br>1275 West 6^th^ Avenue<br><br>Suite 300<br><br>Vancouver, British Columbia<br><br>V6H 1A6 | |
| Item 2 | Date of Material Change |
| June 9, 2020 | |
| Item 3 | News Releases |
| News release dated June 9, 2020. | |
| Item 4 | Summary of Material Change |
| The Company announce that the Financial Industry Regulatory Authority, Inc. ("FINRA") has approved the Company’s request to change its OTC ticker symbol from PVOTF to BETRF, effective as of the opening of market trading on June 9, 2020. | |
| Item 5 | Full Description of Material Change |
| Refer to Item 4 and the news release in Schedule “A”. | |
| Item 6 | Reliance on subsection 7.1(2) or (3) of National Instrument 51-102 |
| This Report is not being filed on a confidential basis in reliance on subsection 7.1(2) of National Instrument 51-102. | |
| Item 7 | Omitted Information |
| No information has been omitted on the basis that it is confidential information. | |
| Item 8 | Executive Officer |
| Further information can be obtained from Ahmad Doroudian, Chief Executive Officer of the Company, at (604) 221-0595. | |
| Item 9 | Date of Report |
| June 9, 2020 |
| 1 |
|---|
SCHEDULE “A”
| 2 |
|---|
BetterLife Pharma Announces OTC Trading Symbol Change to
“BETRF” Effective June 9, 2020
VANCOUVER, June 9, 2020 - BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAT) is pleased to announce that the Financial Industry Regulatory Authority, Inc. ("FINRA") has approved the Company’s request to change its OTC ticker symbol from PVOTF to BETRF, effective as of the opening of market trading on June 9, 2020.
No action is required to be taken by current shareholders with relation to the trading symbol change. BetterLife’s common shares will continue to trade on the Canadian Securities Exchange (CSE) under the symbol CSE: BETR, as well as the Frankfurt Stock Exchange under the symbol FRA: NPAT.
About BetterLife Pharma Inc.
BetterLife Pharma Inc. is a science-based innovative medical wellness company aspiring to offer high-quality preventive and self-care products to its customers. For further information please visit abetterlifepharma.com.
Contact:
Ahmad Doroudian, Chief Executive Officer
Email: Ahmad.Doroudian@blifepharma.com
Phone: 604-221-0595
Cautionary Note Regarding Forward-Looking Statements
All statements, other than statements of historical fact, included herein are forward-looking statements that involve various risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements.
| 3 |
|---|